Functional importance of apolipoprotein A5 185G in the activation of lipoprotein lipase

Clinica Chimica Acta

Volumn 413, Issue 1-2, 2012, Pages 246-250

  Huang, Yi Jan ^a   Lin, Yen Lin ^a   Chiang, Chi I ^a   Yen, Ching Tzu ^a   Lin, Shu Wha ^a,b   Kao, Jau Tsuen ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Apolipoprotein A5; Lipoprotein lipase; Mutagenesis; Mutant; Triglyceride

Indexed keywords

1,2 DIMYRISTOYL SN GLYCERO 3 PHOSPHATIDYLCHOLINE; APOLIPOPROTEIN A5; ARGININE; COMPLEMENTARY DNA; CYSTEINE; GLYCINE; LIPOPROTEIN LIPASE; PHOSPHATIDYLCHOLINE; PROLINE; PROTEIN VARIANT; RECOMBINANT PROTEIN; THREONINE; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LIPID HYDROLYSIS; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SITE DIRECTED MUTAGENESIS;

APOLIPOPROTEINS A; BASE SEQUENCE; DNA PRIMERS; DNA, COMPLEMENTARY; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LIPOPROTEIN LIPASE; MUTAGENESIS, SITE-DIRECTED; POLYMERASE CHAIN REACTION; PROTEOLYSIS; RECOMBINANT PROTEINS;

ESCHERICHIA COLI;

EID: 82955162726     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.09.045     Document Type: Article

References (25)

1. Assmann G., Schulte H., von Eckardstein A. Hypertriglyceridemia and increased levels of lipoprotein (a) are risk factors for major coronary events in middle-aged men. Am J Cardiol 1996, 77:1179-1184.
2. Hokanson J.E., Austin M.A. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996, 3:213-219.
3. Jeppesen J., Hein H.O., Suadicani P., Gyntelberg F. Triglyceride concentration and ischemic heart disease-an eight-year follow-up in the Copenhagen male study. Circulation 1998, 97:1029-1036.
4. Pennacchio L.A., Olivier M., Hubacek J.A., et al. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 2001, 294:169-173.
5. O'Brien P.J., Alborn W.E., Sloan J.H., et al. The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low. Clin Chem 2005, 51:351-359.
6. Ishihara M., Kujiraoka T., Iwasaki T., et al. A sandwich enzyme-linked immunosorbent assay for human plasma apolipoprotein A-V concentration. J Lipid Res 2005, 46:2015-2022.
7. Schaap F.G., Rensen P.C., Voshol P.J., et al. ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis. J Biol Chem 2004, 279:27941-27947.
8. Merkel M., Loeffler B., Kluger M., et al. Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase. J Biol Chem 2005, 280:21553-21560.
9. Fruchart-Najib J., Bauge E., Niculescu L.S., et al. Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5. Biochem Biophys Res Commun 2004, 319:397-404.
10. Kao J.T., Wen H.C., Chien K.L., Hsu H.C., Lin S.W. A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia. Hum Mol Genet 2003, 12:2533-2539.
11. Hsu L.A., Ko Y.L., Chang C.J., et al. Genetic variations of apolipoprotein A5 gene is associated with the risk of coronary artery disease among Chinese in Taiwan. Atherosclerosis 2006, 185:143-149.
12. Yamada Y., Ichihara S., Kato K., et al. Genetic risk for metabolic syndrome: examination of candidate gene polymorphisms related to lipid metabolism in Japanese people. J Med Genet 2008, 45:22-28.
13. Beckstead J.A., Oda M.N., Martin D.D.O., et al. Structure-function studies of human apolipoprotein A-V: a regulator of plasma lipid homeostasis. Biochemistry 2003, 42:9416-9423.
14. Dyke M.W.V., Sirito M., Sawadogo M. Single-step purification of bacterially expressed polypeptides containing an oligo-histidine domain. Gene 1992, 111:99-104.
15. Lindgren F.T., Jensen L.C., Hatch F.T. Blood lipids and lipoproteins: quantitation, composition, and metabolism 1972, Wiley-Interscience, New York. G.J. Nelson (Ed.).
16. Matsunaga A., Arishima H., Niimura H., et al. Strong linkage disequilibrium and association of -1131T>C and c.553G>T polymorphisms of the apolipoprotein A5 gene with hypertriglyceridemia in a Japanese population. Circ J 2007, 71:746-752.
17. Chien K.L., Fang W.H., Wen H.C., et al. APOA1/C3/A5 haplotype and risk of hypertriglyceridemia in Taiwanese. Clin Chim Acta 2008, 390:56-62.
18. Dorfmeister B., Zeng W.W., Dichlberger A., et al. Effects of six APOA5 variants, identified in patients with severe hypertriglyceridemia, on in vitro lipoprotein lipase activity and receptor binding. Arterioscler Thromb Vasc Biol 2008, 28:1866-1871.
19. Weinberg R.B., Cook V.R., Beckstead J.A., et al. Structure and interfacial properties of human apolipoprotein A-V. J Biol Chem 2003, 278:34438-34444.
20. Sun G.T., Bi N., Li G.P., et al. Identification of lipid binding and lipoprotein lipase activation domains of human apoAV. Chem Phys Lipids 2006, 143:22-28.
21. Lookene A., Beckstead J.A., Nilsson S., Olivecrona G., Ryan R.O. Apolipoprotein A-V-heparin interactions: implications for plasma lipoprotein metabolism. J Biol Chem 2005, 280:25383-25387.
22. Nilsson S.K., Lookene A., Beckstead J.A., Gliemann J., Ryan R.O., Olivecrona G. Apolipoprotein A-V interaction with members of the low density lipoprotein receptor gene family. Biochemistry 2007, 46:3896-3904.
23. Beigneux A.P., Davies B.S., Gin P., et al. Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons. Cell Metab 2007, 5:279-291.
24. Lai C.Q., Arnett D.K., Corella D., et al. Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN study. Arterioscler Thromb Vasc Biol 2007, 27:1417-1425.
25. Chien K.L., Lin Y.L., Wen H.C., et al. Common sequence variant in the lipoprotein lipase gene conferring triglyceride response to fibrate treatment. Pharmacogenomics 2009, 10:267-276.